Sunday, July 21, 2024
Home Tags UCI Health

Tag: UCI Health

NeuroRx starts Phase 2/3 study of inhaled ZYESAMI

NeuroRx, Inc. has announced initiation of a Phase 2/3 clinical trial investigating the role of inhaled ZYESAMI (aviptadil). The trial is being done for the...